Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.44 |
| ▸ | CCR1 | P32246 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PI4KA | P42356 | 1/20 | 0.32 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.32 |
| ▸ | TOP2A | P11388 | 1/20 | 0.32 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26241406 | 0.89 | NOS3 (0.45) | GRIN2DGRIN3BCHRM1ADRA1DADRA1A | |
| SCHEMBL5865335 | 0.84 | GRIN2D (0.39) | GRIN2DGRIN3BCHRM1ADRA1DADRA1A | |
| SCHEMBL31042999 | 0.84 | GRIN2D (0.39) | GRIN2DGRIN3BCHRM1ADRA1DADRA1A | |
| SCHEMBL22556943 | 0.84 | GRIN2D (0.39) | GRIN2DGRIN3BCHRM1ADRA1DADRA1A | |
| SCHEMBL9023790 | 0.77 | CCR1 (0.42) | CCR1ACHEPIK3CAPI4KAPI4KB | |
| SCHEMBL4270536 | 0.74 | ACHE (0.52) | CCR1ACHEALDH1A1KDM4EHPGD | |
| SCHEMBL2014831 | 0.72 | SMN1; SMN2 (0.39) | KCNH2ALDH1A1KDM4ETHRBASIC3 | |
| SCHEMBL14721449 | 0.72 | CCR1 (0.39) | CCR1ACHEALDH1A1KDM4EHPGD | |
| SCHEMBL7274937 | 0.72 | NOS2 (0.54) | GRIN2DGRIN3BCHRM1ADRA1DADRA1A | |
| SCHEMBL12161257 | 0.72 | NOS2 (0.43) | CCR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119242161-A | Preparation method of plastic runway glue solution and plastic runway | 湖北金五环体育设施有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-119242161-A | Preparation method of plastic runway glue solution and plastic runway | 湖北金五环体育设施有限公司 | 2025-01-03 | — | — | CN | disclosed |
| US-9486544-B2 | Manganese chelates and their use as contrast agents in magnetic resonance imaging (MRI) | GE HEALTHCARE AS (NO) | 2016-11-08 | — | — | US | disclosed |
| US-9486544-B2 | Manganese chelates and their use as contrast agents in magnetic resonance imaging (MRI) | GE HEALTHCARE AS (NO) | 2016-11-08 | — | — | US | disclosed |
| US-9486544-B2 | Manganese chelates and their use as contrast agents in magnetic resonance imaging (MRI) | GE HEALTHCARE AS (NO) | 2016-11-08 | — | — | US | disclosed |
| EP-2512524-B1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2016-10-05 | — | — | EP | disclosed |
| EP-2512524-B1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2016-10-05 | — | — | EP | disclosed |
| EP-2512524-A1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE Healthcare AS (NO) | 2012-10-24 | — | — | EP | disclosed |
| US-20120244081-A1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2012-09-27 | — | — | US | disclosed |
| US-20120244081-A1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2012-09-27 | — | — | US | disclosed |
| US-20120244081-A1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2012-09-27 | — | — | US | disclosed |
| WO-2011073371-A1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073371-A1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | GE HEALTHCARE AS (NO) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120244081-A1 | MANGANESE CHELATES AND THEIR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING (MRI) | MAG, MPI, MB | GRIN2D 2118/4885GRIN3B 397/4885CHRM1 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.